MedPath

The Effect of Intra-articular Pulsed Radiofrequency in Osteoarthritis

Not Applicable
Withdrawn
Conditions
Osteoarthritis
Interventions
Device: pulsed radiofrequency (Neurotherm NT1000, Neurotherm Inc., USA)
Registration Number
NCT02436434
Lead Sponsor
Tri-Service General Hospital
Brief Summary

Pulsed radiofrequency (PRF) is designed to alleviate pain by delivering an electrical field and heat bursts at a temperature less than 42°C to neural tissue. In contrast with conventional radiofrequency, PRF is controlled below 42°C without damage to nerves and many studies have shown its benefits in pain relief for certain kinds of chronic pain conditions. For lessening pain of certain joint arthropathy, the direct nerve block by application of PRF is difficult and complicated because the supplying nerve of joint is complex or small. Hence, some authors perform intra-articular PRF on the chronic painful joint for example, knee osteoarthritis, atlantoaxial joint, cervical facet joint sacroiliac joint, scapholunate and shoulder joint and the excellent long-term effects are reported.

The purpose of this study is to investigate the effect of intra-articular PRF in osteoarthritis.

Detailed Description

Pulsed radiofrequency (PRF) is designed to alleviate pain by delivering an electrical field and heat bursts at a temperature less than 42°C to neural tissue. In contrast with conventional radiofrequency, PRF is controlled below 42°C without damage to nerves and many studies have shown its benefits in pain relief for certain kinds of chronic pain conditions. For lessening pain of certain joint arthropathy, the direct nerve block by application of PRF is difficult and complicated because the supplying nerve of joint is complex or small. Hence, some authors perform intra-articular PRF on the chronic painful joint for example, knee osteoarthritis, atlantoaxial joint, cervical facet joint sacroiliac joint, scapholunate and shoulder joint and the excellent long-term effects are reported.

However, the definite effect of intra-articular PRF for osteoarthritis from current published studies are insufficiently proved because of small patient numbers and lack of placebo-controlled design. The purpose of this study is to investigate the effect of intra-articular PRF in osteoarthritis.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age between 30-75 year-old
  • Clear consciousness
  • No receive steroid injection, hyaluronic acid, platelet rich plasma in past 6 months
  • The pain (VAS) more than 4
  • Symptom duration at least 6 months
Exclusion Criteria
  • Cancer
  • Joint contracture
  • Coagulopathy
  • Pregnancy
  • Status of Pacemaker
  • Inflammation status
  • Operative history of treated joint

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham pulsed radiofrequencypulsed radiofrequency (Neurotherm NT1000, Neurotherm Inc., USA)Sham intra-articular pulsed radiofrequency (Neurotherm NT1000, Neurotherm Inc., USA) in controlled joint
pulsed radiofrequencypulsed radiofrequency (Neurotherm NT1000, Neurotherm Inc., USA)Intra-articular pulsed radiofrequency (Neurotherm NT1000, Neurotherm Inc., USA) in treated joint
Primary Outcome Measures
NameTimeMethod
Change from baseline of pain on1st, 2th, 4th, 8th,12th and 16th weeks after treatment.Pre-treatment, 1st, 2th, 4th, 8th,12th and 16th weeks after treatment.

Using the Visual analog scale (VAS) to measure the pain scale before treatment and multiple time frame after treatment.

Secondary Outcome Measures
NameTimeMethod
Change from baseline of range of motion on1st, 2th, 4th, 8th,12th and 16th weeks after treatment.Pre-treatment, 1st, 2th, 4th, 8th,12th and 16th weeks after treatment.

Use the goniometer to measure the ROM before treatment and multiple time frame after treatment.

Change from baseline in severity of symptoms and functional status on1st, 2th, 4th, 8th,12th and 16th weeks after treatment.Pre-treatment, 1st, 2th, 4th, 8th,12th and 16th weeks after treatment.

Use the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) to measure the symptoms and functional status before treatment and multiple time frame after treatment.

Change from baseline of strength on 4th, 8th,12th and 16th weeks after treatment.Pre-treatment 4th, 8th,12th and 16th weeks after treatment.

Use the isokinetic machine to measure the ROM before treatment and multiple time frame after treatment.

Trial Locations

Locations (2)

Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital

🇨🇳

Taipei, Neihu District, Taiwan

Tri-Service General Hospital, National Defense Medical Center,

🇨🇳

Taipei, Neihu District, Taiwan

© Copyright 2025. All Rights Reserved by MedPath